Alpha 2.0
Login Register
» Articles » PMID: 34161631

Impact of Philadelphia Chromosome-like Alterations on Efficacy and Safety of Blinatumomab in Adults with Relapsed/refractory Acute Lymphoblastic Leukemia: A Post Hoc Analysis from the Phase 3 TOWER Study

Overview
Journal Am J Hematol
Specialty Hematology
Date 2021 Jun 23
PMID 34161631
Citations 7
Authors
Elias Jabbour
Keyur Patel
Nitin Jain
Dzifa Duose
Rajyalakshmi Luthra
Nicholas J Short
Gerhard Zugmaier
Anthony San Lucas
Kelly Velasco
Qui Tran
Faraz Zaman
Marina Konopleva
Hagop Kantarjian
Affiliations
Soon will be listed here.
Citing Articles

Antibody-Based and Other Novel Agents in Adult B-Cell Acute Lymphoblastic Leukemia.

Csizmar C, Litzow M, Saliba A Cancers (Basel). 2025; 17(5).

PMID: 40075627 PMC: 11899621. DOI: 10.3390/cancers17050779.

Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.

Zhao Y, Laird A, Roberts K, Yafawi R, Kantarjian H, DeAngelo D Blood Adv. 2024; 8(12):3226-3236.

PMID: 38607410 PMC: 11225676. DOI: 10.1182/bloodadvances.2023012430.

[Efficacy and safety of chimeric antigen receptor T-cell therapy followed by allogeneic hematopoietic stem cell transplantation in 21 patients with Ph-like acute lymphoblastic leukemia].

Dai H, Shen H, Li Z, Cui W, Cui Q, Li M Zhonghua Xue Ye Xue Za Zhi. 2024; 45(1):35-40.

PMID: 38527836 PMC: 10951118. DOI: 10.3760/cma.j.cn121090-20230929-00154.

Challenges to successful outcomes in AYAs with ALL and potential solutions.

Anandappa A, Curran E Hematology Am Soc Hematol Educ Program. 2023; 2023(1):587-592.

PMID: 38066918 PMC: 10727044. DOI: 10.1182/hematology.2023000512.

Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.

Tan K, Zhu Y, Qiu Q, Wang M, Shen H, Huang S Ann Hematol. 2023; 102(9):2397-2402.

PMID: 37103615 DOI: 10.1007/s00277-023-05236-z.